Comparison of the effect of Agnugol, Cimifugol , Soyagol , vitagnus and EsCitalopram
Phase 3
Recruiting
- Conditions
- Menopause.Menopausal and female climacteric statesN95.1
- Registration Number
- IRCT20080902001181N4
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Obtaining a score of 5 and above from the MRS questionnaire
12 months or more have passed since menopause
Age between 45 and 65 years
Exclusion Criteria
Presence or history of breast and uterine cancer, abnormal vaginal bleeding, liver, kidney, thyroid, depression and known anxiety disorders.
Use of progestins, contraceptive pills, GNRH agonists and antagonists
Taking drugs that interact with the studied drugs, such as warfarin, tamoxifen, antipsychotics, and dopamine antagonists.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total score of menopausal symptoms. Timepoint: The total score of menopausal symptoms is checked at the beginning of the study (before the start of the intervention), the fourth and the eighth week after the start of the intervention. Method of measurement: Menopause Rating Scale (MRS).
- Secondary Outcome Measures
Name Time Method